VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F900. A total of 6 filers reported holding VERTEX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 2.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $390,000 | +13.0% | 3,100 | +6.9% | 0.01% | +16.7% |
| Q4 2014 | $345,000 | -26.9% | 2,900 | -31.0% | 0.01% | -33.3% |
| Q3 2014 | $472,000 | -71.5% | 4,200 | -76.0% | 0.01% | -65.4% |
| Q2 2014 | $1,657,000 | +23.9% | 17,500 | -7.4% | 0.03% | +52.9% |
| Q1 2014 | $1,337,000 | +87.5% | 18,900 | +96.9% | 0.02% | +112.5% |
| Q4 2013 | $713,000 | -58.4% | 9,600 | -57.5% | 0.01% | -63.6% |
| Q3 2013 | $1,714,000 | – | 22,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WINTRUST INVESTMENTS LLC | 2,700 | $492,000 | 0.05% |
| GROUP ONE TRADING, L.P. | 153,800 | $40,137,000 | 0.04% |
| SG Americas Securities, LLC | 100,500 | $3,032,000 | 0.02% |
| SIMPLEX TRADING, LLC | 69,500 | $18,137,000 | 0.02% |
| IMC-Chicago, LLC | 18,200 | $4,750,000 | 0.01% |
| HRT FINANCIAL LP | 900 | $234,000 | 0.00% |
| Allianz Asset Management GmbH | 800 | $209,000 | 0.00% |
| JPMORGAN CHASE & CO | 15,000 | $3,915,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |